Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas
- PMID: 33745191
- DOI: 10.1111/cen.14467
Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas
Abstract
Objective: Few and conflicting reports have characterized the genetics of paediatric pheochromocytomas and paragangliomas (PPGLs). This study aimed to investigate the clinical and genetic features of Brazilian children with PPGL.
Patients and methods: This study included 25 children (52% girls) with PPGL. The median age at diagnosis was 15 years (4-19). The median time of follow-up was 145 months. The genetic investigation was performed by Sanger DNA sequencing, multiplex ligation-dependent probe amplification and/or target next-generation sequencing panel.
Results: Of the 25 children with PPGL, 11 (44%), 4 (16%), 2 (8%), 1 (4%) and 7 (28%) had germline VHL pathogenic variants, SDHB, SDHD, RET and negative genetic investigation, respectively. Children with germline VHL missense pathogenic variants were younger than those with SDHB or SDHD genetic defects [median (range), 12 (4-16) vs. 15.5 (14-19) years; P = .027]. Moreover, 10 of 11 cases with VHL pathogenic variants had bilateral pheochromocytoma (six asynchronous and four synchronous). All children with germline SDHB pathogenic variants presented with abdominal paraganglioma (one of them malignant). The two cases with SDHD pathogenic variants presented with head and neck paraganglioma. Among the cases without a genetic diagnosis, 6 and 2 had pheochromocytoma and paraganglioma, respectively. Furthermore, metastatic PPGL was diagnosed in four (16%) of 25 PPGL.
Conclusions: Most of the paediatric PPGL were hereditary and multifocal. The majority of the affected genes belong to pseudohypoxic cluster 1, with VHL being the most frequently mutated. Therefore, our findings impact surgical management and surveillance of children with PPGL.
Keywords: children; genetics; paraganglioma; pheochromocytoma.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.Front Endocrinol (Lausanne). 2020 Dec 11;11:574662. doi: 10.3389/fendo.2020.574662. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33362715 Free PMC article. Clinical Trial.
-
Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.Clin Genet. 2014 Nov;86(5):482-6. doi: 10.1111/cge.12304. Epub 2013 Nov 15. Clin Genet. 2014. PMID: 24134185
-
Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.Endocrinol Metab (Seoul). 2020 Dec;35(4):858-872. doi: 10.3803/EnM.2020.683. Epub 2020 Dec 23. Endocrinol Metab (Seoul). 2020. PMID: 33397040 Free PMC article.
-
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101416. doi: 10.1016/j.beem.2020.101416. Epub 2020 Mar 10. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32295730 Review.
-
Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review.Ann Lab Med. 2024 Nov 1;44(6):591-597. doi: 10.3343/alm.2023.0376. Epub 2024 Jul 29. Ann Lab Med. 2024. PMID: 39069753 Free PMC article. Review.
Cited by
-
Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.Front Endocrinol (Lausanne). 2022 Jul 12;13:936178. doi: 10.3389/fendo.2022.936178. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35903274 Free PMC article. Review.
-
Focus on adrenal and related causes of hypertension in childhood and adolescence: Rare or rarely recognized?Arch Endocrinol Metab. 2022 Nov 17;66(6):895-907. doi: 10.20945/2359-3997000000507. Epub 2022 Aug 4. Arch Endocrinol Metab. 2022. PMID: 35929903 Free PMC article. Review.
-
[Preclinical diagnostics of von Hippel-Lindau syndrome in a child].Probl Endokrinol (Mosk). 2024 Feb 28;70(1):100-104. doi: 10.14341/probl13280. Probl Endokrinol (Mosk). 2024. PMID: 38433546 Free PMC article. Russian.
-
Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.Front Endocrinol (Lausanne). 2022 Jul 26;13:901760. doi: 10.3389/fendo.2022.901760. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35957826 Free PMC article. Review.
-
Pediatric and adolescent von Hippel-Lindau disease: tumor profiles, genotype-phenotype correlation and comparison with adults.J Endocrinol Invest. 2025 Jul;48(7):1635-1647. doi: 10.1007/s40618-025-02571-y. Epub 2025 Apr 28. J Endocrinol Invest. 2025. PMID: 40293648
References
REFERENCES
-
- Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2014;99(6):1915-1942.
-
- Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27(3):193-202.
-
- Wyszynska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr. 1992;81(3):244-246.
-
- Dahia PLM, Clifton-Bligh R, Gimenez-Roqueplo AP, Robledo M, Jimenez C. Hereditary endocrine tumours: current state-of-the-art and research opportunities: Metastatic pheochromocytomas and paragangliomas: proceedings of the Men 2019 workshop. Endocr Relat Cancer. 2020;27(8):T41-T52.
-
- Bholah R, Bunchman TE. Review of Pediatric Pheochromocytoma and Paraganglioma. Front Pediatr. 2017;5:155.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical